RFA-AI-24-041: Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Exploratory/Developmental Research Grant)

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web   RFA-AI-24-041: Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Exploratory/Developmental Research Grant)   The purpose of this Notice of Funding Opportunity (NOFO) is to support exploratory and conceptual research projects in radiation research focused on medical countermeasures, biodosimetry, and animal model development to diagnose/mitigate/treat injuries arising from radiation exposure sustained during a radiation mass casualty incident. This NOFO is intended to support the development of preliminary data to help advance high-risk, high-reward projects needed for a robust early product development pipeline that can lead to the advancement of much-needed radiation-exposure-related tools and products.     Application Due Date - November 1, 2024 Scientific Merit Review - April 2025   Earliest Start Date - July 2025  Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107